NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in NextCure, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −4 vs. Q2 2024
- Shares held
- 15.9M
- +616.2K (+4.0%) vs. Q2 2024
- Total value
- $21.7M
- −$2.51M (−10.4%) vs. Q2 2024
- New holders
- 3
- 8 more added
- Sold out
- 7
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $1 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 385 | $527 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 807 | $1.11K | 0.00% | +1+0.1% | Added |
| Advisor Group Holdings, Inc. | 1,191 | $1.63K | 0.00% | +1,191 | New |
| Bank of America Corp | 5,390 | $7.38K | 0.00% | +21+0.4% | Added |
| UBS Group AG | 5,466 | $7.49K | 0.00% | −4,462−44.9% | Reduced |
| Charles Schwab Investment Management Inc | 10,000 | $13.7K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 10,044 | $13.8K | 0.01% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 10,774 | $14.8K | 0.00% | +10,774 | New |
| HSBC Holdings PLC | 17,363 | $23.7K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 21,247 | $29.1K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 23,800 | $32.6K | 0.00% | −3,800−13.8% | Reduced |
| LPL Financial LLC | 27,000 | $37.0K | 0.00% | −3,000−10.0% | Reduced |
| Ieq Capital, LLC | 37,342 | $51.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 47,562 | $65.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 55,954 | $76.7K | 0.00% | −233,096−80.6% | Reduced |
| Marquette Asset Management, LLC | 58,259 | $79.8K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 65,392 | $89.6K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 67,518 | $92.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 70,600 | $96.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 72,119 | $98.8K | 0.00% | −386,221−84.3% | Reduced |
| Assenagon Asset Management S.A. | 85,308 | $116.9K | 0.00% | −99,178−53.8% | Reduced |
| Dimensional Fund Advisors LP | 85,853 | $117.6K | 0.00% | −706−0.8% | Reduced |
| Armistice Capital, LLC | 100,000 | $137.0K | 0.00% | +64,000+177.8% | Added |
| Hudson Bay Capital Management LP | 107,672 | $147.5K | 0.00% | −96,128−47.2% | Reduced |
| ADAR1 Capital Management, LLC | 120,013 | $164.4K | 0.03% | +30,999+34.8% | Added |
| Sio Capital Management, LLC | 130,000 | $178.1K | 0.08% | 00.0% | Unchanged |
| Macquarie Group Ltd | 150,000 | $206.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 223,741 | $306.6K | 0.00% | +27,812+14.2% | Added |
| Cardiff Park Advisors, LLC | 262,000 | $358.9K | 0.03% | 00.0% | Unchanged |
| BML Capital Management, LLC | 276,465 | $378.8K | 0.22% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 321,527 | $440.5K | 0.00% | −5,878−1.8% | Reduced |
| Acuitas Investments, LLC | 342,592 | $469.4K | 0.21% | +19,250+6.0% | Added |
| Renaissance Technologies LLC | 406,000 | $556.2K | 0.00% | −56,144−12.1% | Reduced |
| Acadian Asset Management LLC | 488,440 | $667.0K | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 556,105 | $761.9K | 0.07% | 00.0% | Unchanged |
| Cable Car Capital LLC | 615,878 | $843.8K | 0.91% | 00.0% | Unchanged |
| Tang Capital Management LLC | 652,386 | $893.8K | 0.06% | +49,392+8.2% | Added |
| BlackRock, Inc. | 729,836 | $999.9K | 0.00% | +729,836 | New |
| Vanguard Group Inc | 987,324 | $1.35M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,141,200 | $1.56M | 0.03% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 2,302,598 | $3.15M | 0.49% | +614,643+36.4% | Added |
| Logos Global Management LP | 2,500,000 | $3.42M | 0.38% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,671,856 | $3.66M | 0.30% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,874−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,342−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,227−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −703−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −403−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −547−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |